During the past decade, Baylor-Uganda CRS conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor-Uganda CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator, "UNITAID" with 2 trials as a collaborator and "ViiV Healthcare" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Baylor-Uganda CRS" are "HIV Infections" (6 trials), "HIV Infection" (3 trials), "HIV" (2 trials), "COVID-19" (1 trials) and "SARS-CoV-2 Infection" (1 trials). Many other conditions were trialed in "Baylor-Uganda CRS" in a lesser frequency.

Most popular intervention types in "Baylor-Uganda CRS" are "Drug" (10 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABC/3TC/LPV/r granules (30/15/40/10 mgs)" (1 trials), "Atazanavir/ritonavir (ATV/r)" (1 trials), "Behavioral HIV risk reduction package" (1 trials), "Bictegravir (BIC)" (1 trials) and "CAB LA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor-Uganda CRS" are 7 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Baylor-Uganda CRS". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Baylor-Uganda CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor-Uganda CRS, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".